when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

JOURNEY · news · pharmadog

← back to JOURNEY

News mentioning JOURNEY

113 stories

28dHospital and pharmaceutical prices are smothering America’s businessesstat

28dSTAT+: Divergent trial results on cancer vaccines have the field grappling with hard questionsstat

Oct 2, 26Gate CEO sees expanded $870M pact with Lilly as ‘vote of confidence’ in biotech’s platformfiercebiotech

Oct 2, 26STAT+: Lilly bypasses Australian pharmacies with DTC modelstat

Oct 1, 26Top journal’s special issue on women’s health casts spotlight on menopause and painstat

Oct 1, 26STAT+: A journey to witness China’s biotech boom up closestat

Sep 30, 26STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and morestat

Sep 29, 26There Is No Such Thing as a Typical Biotechfiercebiotech

Sep 29, 26uniQure stock crashes as Huntington’s gene therapy data weakenfiercebiotech

Sep 29, 26Why MAHA wants to make health data much more accessiblestat

Sep 28, 26‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the futurefiercebiotech

Sep 28, 26FDA nod for Mirum’s Atebrioz makes 3 options for ultra-rare bone diseasebiospace

Sep 25, 26After COVID, biomanufacturing tackles preparedness and commercialization challengesbiospace

Sep 25, 26Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drugstat

Sep 24, 26Backed by NVIDIA, Basecamp bags $140M to advance AI-designed drugsbiospace

Sep 24, 26Backed by NVIDIA and Anthropic, Basecamp bags $140M to advance AI-designed drugsbiospace

Sep 23, 26In a changed world for cystic fibrosis, a family's fight reveals a new gap in careendpoints

Sep 22, 26GSK aiming to ‘balance West and East’ after Hansoh deal success showed China’s potentialfiercebiotech

Sep 22, 26Deep Dive: How AI is now essential in biopharmabiospace

Sep 21, 26Behind the outcomes: How whole-patient support is reshaping oncology carebiopharma dive

Sep 20, 26Beacon lights path to FDA approval with pivotal trial win for rare vision loss gene therapyfiercebiotech

Sep 18, 26In Sudan, attacks on hospitals force patients to make dangerous journeysstat

Sep 16, 26U.S. reaches highest number of measles deaths in decadesstat

Sep 16, 26Opinion: How my cancer diagnosis changed the way I train physiciansstat

Sep 15, 26Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near marketbiospace

Sep 15, 26Exercise — and echocardiograms — in space protected astronauts’ hearts in studystat

Sep 10, 26FDA places partial hold on Biohaven’s epilepsy drugbiopharma dive

Sep 9, 26Telemedicine company offers GLP-1s for addictionstat

Sep 9, 26Steady stream of crossover rounds stock biotech's IPO pipelinebiospace

Sep 8, 26AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPDfiercebiotech

← prevpage 2 of 4next →